PRLD — Prolight Diagnostics AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK62.08m
- SEK48.81m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 10 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 21.9 | 12.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.37 | 4.18 | 6.97 | 10.5 | 28.1 |
Operating Profit | -4.37 | -4.18 | -6.97 | -10.5 | -28.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.13 | -4.3 | -6.86 | -10.2 | -27.8 |
Net Income After Taxes | -4.13 | -4.3 | -6.86 | -10.2 | -27.8 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.13 | -4.3 | -6.86 | -10.2 | -27.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.13 | -4.3 | -6.86 | -10.2 | -27.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.033 | -0.029 | -0.046 | -0.036 | -0.098 |
Dividends per Share |